Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma

被引:4
|
作者
LiLing Luo [1 ,2 ,3 ]
Lei Zhao [1 ,2 ,3 ]
Mian Xi [1 ,2 ,3 ]
LiRu He [1 ,2 ,3 ]
JingXian Shen [1 ,4 ,3 ]
QiaoQiao Li [1 ,2 ,3 ]
ShiLiang Liu [1 ,2 ,3 ]
Peng Zhang [1 ,2 ,3 ]
Dan Xie [1 ,3 ]
MengZhong Liu [1 ,2 ,3 ]
机构
[1] Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine
[2] Department of Radiation Oncology, Sun Yat-sen University Cancer Center
[3] Collaborative Innovation Center for Cancer Medicine
[4] Medical Imaging and Interventional Center, Sun Yat?sen University Cancer
关键词
D O I
暂无
中图分类号
R735.1 [食管肿瘤];
学科分类号
摘要
Background: Insulin?like growth factor?binding protein?3(IGFBP?3) is suggested to predict the radiosensitivity and/or prognosis of patients with esophageal squamous cell carcinoma(ESCC). The present study was designed to investi?gate the clinical and prognostic efects of IGFBP?3 on ESCC.Methods: IGFBP?3 was detected by immunohistochemistry in parain?embedded tissues from 70 ESCC patients treated with radiotherapy alone and further examined by western blotting analysis in 10 pairs of fresh ESCC tissues and adjacent non?malignant esophageal specimens. Receiver operating characteristic(ROC) analysis was used to determine cut?of scores for tumor positivity and to evaluate patient survival status. The χ2 test was performed to analyze the association of IGFBP?3 expression with clinical characteristics and radiotherapy response. Associations between prognostic outcomes and IGFBP?3 expression were investigated using Kaplan–Meier analysis and the Cox proportional hazards model.Results: The threshold for IGFBP?3 positivity was set to greater than 65% [area under the ROC curve(AUC)(45.7%) were deined as having high IGFBP?3 expression= 0.690, P < 0.019]. Of the 70 ESCC patient tissues tested, 32. The levels of IGFBP?3 protein expression were decreased in 70.0%(7 of 10) of ESCC tissues compared with adjacent non?malignant esophageal tissue. In addition, IGFBP?3 expression was associated with pathologic classiication(P < 0.05 for T, N, and M categories and clinical stage). Patients with elevated protein level of IGFBP?3 in the tumor had an improved radiotherapy response and prolonged overall survival(P < 0.001).Conclusions: High level of IGFBP?3 expression in ESCC associates with early clinical stages and are predictive for favorable survival of the patients treated with radiotherapy.
引用
收藏
页码:514 / 521
页数:8
相关论文
共 50 条
  • [1] Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma
    Luo, Li-Ling
    Zhao, Lei
    Xi, Mian
    He, Li-Ru
    Shen, Jing-Xian
    Li, Qiao-Qiao
    Liu, Shi-Liang
    Zhang, Peng
    Xie, Dan
    Liu, Meng-Zhong
    CHINESE JOURNAL OF CANCER, 2015, 34
  • [2] Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma
    Luo, Li-Ling
    Zhao, Lei
    Wang, Ying-Xue
    Tian, Xiao-Peng
    Xi, Mian
    Shen, Jing-Xian
    He, Li-Ru
    Li, Qiao-Qiao
    Liu, Shi-Liang
    Zhang, Peng
    Xie, Dan
    Liu, Meng-Zhong
    SCIENTIFIC REPORTS, 2015, 5
  • [3] Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma
    Li-Ling Luo
    Lei Zhao
    Ying-Xue Wang
    Xiao-Peng Tian
    Mian Xi
    Jing-Xian Shen
    Li-Ru He
    Qiao-Qiao Li
    Shi-Liang Liu
    Peng Zhang
    Dan Xie
    Meng-Zhong Liu
    Scientific Reports, 5
  • [4] Transferrin is an insulin-like growth factor-binding protein-3 binding protein
    Weinzimer, SA
    Gibson, TB
    Collett-Solberg, PF
    Khare, A
    Liu, BR
    Cohen, P
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04): : 1806 - 1813
  • [5] GLUCOCORTICOID REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-3
    VILLAFUERTE, BC
    KOOP, BL
    PAO, CI
    PHILLIPS, LS
    ENDOCRINOLOGY, 1995, 136 (05) : 1928 - 1933
  • [6] Polymorphisms of insulin-like growth factor binding protein-3 as a predictor for risk and patient survival in esophageal squamous cell carcinoma
    Zhao, Lei
    Chi, Feng
    Xi, Mian
    Shen, Jing-Xian
    Li, Qiao-Qiao
    He, Li-Ru
    Liu, Shi-Liang
    Liu, Meng-Zhong
    BIOMEDICINE & PHARMACOTHERAPY, 2015, 74 : 148 - 152
  • [7] Serum insulin-like growth factor binding protein-3 as a potential biomarker for diagnosis and prognosis of oesophageal squamous cell carcinoma
    Luo, Yun
    Hong, Chao-Qun
    Huang, Bin-Liang
    Ding, Tian-Yan
    Chu, Ling-Yu
    Zhang, Biao
    Qu, Qi-Qi
    Li, Xin-Hao
    Liu, Can-Tong
    Peng, Yu-Hui
    Guo, Hai-Peng
    Xu, Yi-Wei
    ANNALS OF MEDICINE, 2022, 54 (01) : 2153 - 2166
  • [8] Bovine lactoferrin binds to insulin-like growth factor-binding protein-3
    Baumrucker, CR
    Gibson, CA
    Schanbacher, FL
    DOMESTIC ANIMAL ENDOCRINOLOGY, 2003, 24 (04) : 287 - 303
  • [9] Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3
    Chan, Sophie S. Y.
    Schedlich, Lynette J.
    Twigg, Stephen M.
    Baxter, Robert C.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2009, 296 (04): : E654 - E663
  • [10] Insulin-like growth factor-binding protein-3 binds fibrinogen and fibrin
    Campbell, PG
    Durham, SK
    Hayes, JD
    Suwanichkul, A
    Powell, DR
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (42) : 30215 - 30221